Oem / odm china da sauri ya gwada jarumawan mutum - Rapid 2019 - NCov Coronavirus Antigen Gwajin - MIMUTO
Oem / odm china da sauri ya gwada jarumawan mutum - Rapid 2019 - NCov Coronavirus Antigen Gwajin - Immungetail:
Im imminbox rapid antigen kit na gwajin ganowa mai sauri na COVID - 19 antigen. Anti - 2019 - NCOV Monoclonal Antibodal da aka rufe a kan layin gwaji kuma conjugated gwajin - 2019 - NCov Antibody Conjugate a cikin gwajin gwajin. A cakuda sannan kuma ya yi hijira sama da membrane ta hanyar aiki mai kyau kuma an mayar da shi tare da wani anti - 2019 - NCOV Monoconal antibodal daga gwajin yankin.
Kit ɗin gwajin rigakafi na rigakafi ne mai saurin gwaji don ganowa mai maganin rigakafi ga coronavirus da Sudewar jiki. Don ƙwararru a cikin amfani da bincike na vitro kawai
Halaye na aiki
1. Siyayya, da dama da daidaito SARS - COV - 2 Antigen Rapid (COVID - 19 agD) an kwatanta shi da ingantaccen tsarin kasuwanci (PCR). Sakamakon ya nuna masaniyar dangi da takamaiman bayani
| Hanya | Gold Standard Reagent (PCR) | Jimlar sakamakon | ||
| SARS - Cov - 2 Antigen Rapid (COVID - 19 AG) | Sakamako | M | M | |
| M | 87 | 0 | 87 | |
| M | 4 | 300 | 304 | |
| Jimlar sakamako | 60 | 300 | 391 | |
Dangi na dangi: 95.60% (95% ci: 88.89% ~ 98.63%)
Zamani da dama: 100% (95% ci: 98.78% ~ 100.00%)
Tabbatarwa: 98.98% (95% ci: 97.30% ~ 99.70%)
2. Iyakar ganewa (LOD)
Iyakar ganowar SARS - COV - 2 Antigen Rapid (COVID - 19 agd) ya yi nazari. Lod na gwajin zuwa SARS - Cov - 2 NUNA NA 0.2 - 0.5ng / ML. 2 virus (inact102 Tcid50/ ml
| Taro | Tabbatacce / sakamako | Yawan yarjejeniya |
| 0 5ng / ml n furotin | 100/100 | 100% |
| 5x102 Tcid50/ ml | 100/100 | 100% |
3. Cross - Ra'ayoyi:
SARS - COV - 2 Antigen Rapid (COVID - 19 agr) yana da alaƙa da wani kwamitin na sunadaran da sauran moronavirs ya haifar da maganin rigakafi da cutar usigens da sauran cutar cututtukan cututtukan jini. Sakamakon ya nuna a cikin Shafin da ke ƙasa:
| Abu | Taro | Sakamako |
| SARS - COV - 2 n furotin | 0.001μg / ml | m |
| SARS - Cov N furotin | 1μg / ml | m |
| MERS - Cov N furotin | 1μg / ml | m |
| HCOV - NL63 N furotin | 1μg / ml | m |
| HCOV - 229e N furotin | 1μg / ml | m |
| HCOV - HKU1 N furotin | 1μg / ml | m |
| Varusara virs | 1x105Tcid50/ ml | m |
| Cutar mura da kwayar cuta | 1x105Tcid50/ ml | m |
| Cutar m mura | 1x105Tcid50/ ml | m |
| Chlamydia pneumoniae | 1x105Tcid50/ ml | m |
| Adenovirus | 1x105Tcid50/ ml | m |
| Mycoplasma pneumoniae | 1x105Tcid50/ ml | m |
| Ƙwayar cutar da ke kama huhu | 1x105Tcid50/ ml | m |
4. Fita abubuwa:
An gwada mahimman mahadi ta amfani da SARS - 2 ga Antigen Rapid (COVID - 19 ag) kuma ba a lura da tsangwama ba.
Abu | Taro | Sakamako |
Alpha - Intereferon | 3Millioniu | Babu tsangwama |
Murcin | 1000ng / ml | Babu tsangwama |
Izni takardar shaida
1. I / iso13485 / Jerin Jerin farin
2. Rajista a cikin ma'aikatar kiwon lafiya na Jamus
Hanya gwaji
Cikakken hotuna:
Jagorar samfurin mai alaƙa:
Kamfaninmu ya nace dukkan manufofin ingancin "ingantaccen ingancin tsarin ciniki; cikar cigaba zai zama kyakkyawan tsari na har abada shine rashin daidaituwa na" suna na farko , shago na farko "gooem / odm china da sauri ya gwada dan Adam coronavirus - Rapid 2019 - NCov Coronavirus Antigen Gwajin Gwajin - Immuno, samfurin zai wadata zuwa ga duk duniya, kamar: Bolivia, Iran, don ƙara yawan mutane, mun yaba da yawa Hankali ga kayan aikin fasaha da ci gaba, har ma da maye gurbin kayan aiki. A ƙarshe amma ba ƙarami bane, kuma zamu iya ba da ƙarin kulawa don horar da takardun kula da mu, masu fasaha da ma'aikata a kan hanyar da aka shirya.